Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Abroad (travel likely)RecruitingPHASE4

Conditions

Crohn Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Children's Hospital, Capital Medical University, Beijing, China
Contact: Study coordinator (Wu Jie) · licli2860@sina.com · 18940251108

Study leads

Wu Jie
Principal Investigator
Beijing Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Ghent, Belgium · Ostend, Belgium

Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Winnipeg, Canada

Study on the Treatment of Anal Fistulas Using Alofisel Versus Fat Autologous Stem Cells

Crohn Disease · Anal Fistula

Abroad (travel likely)Recruiting

Nantes, France

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Crohn Disease (CD)

Abroad (travel likely)Recruiting

Antwerp, Belgium · Bonheiden, Belgium